Expansion of neonatal tolerance to self in adult life: I. The role of a bacterial adjuvant in tolerance spread

International Immunology

Volumn 11, Issue 6, 1999, Pages 899-906

  Grabie, Nir ^a   Wohl, Ishay ^a   Youssef, Sawsan ^a   Wildbaum, Gizi ^a   Karin, Nathan ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Complete freund's adjuvant; Determinant spreading; Experimental autoimmune encephalomyelitis; Mycobacterium tuberculosis; Myelin basic protein; Neonatal tolerance

Indexed keywords

EPITOPE; FREUND ADJUVANT; INTERLEUKIN 4; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IN VITRO STUDY; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; T LYMPHOCYTE;

AGING; AMINO ACID SEQUENCE; ANIMALS; ANIMALS, NEWBORN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FREUND'S ADJUVANT; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; RATS; RATS, INBRED LEW; SELF TOLERANCE; TH1 CELLS; TH2 CELLS;

EID: 0033037807     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.6.899     Document Type: Article

References (56)

1. Offner, H., Hashim, G. A., Celnik, B., Galang, A., Li, X. B., Burns, F. R., Shen, N., Heber-Katz, E. and Vandenbark, A. A. 1989. T cell determinants of myelin basic protein include a unique encephalitogenic I-E-restricted epitope for Lewis rats. J. Exp. Med. 170:355.
2. Offner, H., Vainiene, M., Gold, D. P., Celnik, B., Wang, R., Hashim, G. A. and Vandenbark, A. A. 1992. Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. I. T cell receptor peptide regulation of T cell clones expressing cross-reactive V beta genes. J. Immunol. 148:1706.
3. Lehmann, P. V., Forsthuber, T., Miller, A. and Sercarz, E. E. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155.
4. Mor, F. and Cohen, I. R. 1993. Shifts in the epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitis. J. Clin. Invest. 92:2199.
5. Vandenbark, A. A., Vainiene, M., Celnik, B., Hashim, G. A., Buenafe, A. and Offner, H. 1994. Definition of encephalitogenic and immunodominant epitopes of guinea pig myelin basic protein (Gp-BP) in Lewis rats tolerized neonatally with Gp-BP or Gp-BP peptides. J Immunol. 153:852.
6. Clayton, J. P., Gammon, G. M., Ando, D. G., Kono, D. H., Hood, L. and Sercarz, E. E. 1989. Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J. Exp. Med. 169:1681.
7. McRae, B. L., Vanderlugt, C. L., Dal Canto, M. C. and Miller, S. D. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75.
8. Ramsdell, F. and Fowlkes, B. J. 1990. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science 248:1342.
9. Kappler, J., Roehm, N. and Marrack, P. 1987. T cell tolerance by clonal elemination in the thymus. Cell 49:273.
10. Gammon, G. M., Oki, A., Shastri, N. and Sercarz, E. E. 1986. Induction of tolerance to one determinant on a synthetic peptide does not affect the response to a second linked determinant. Implications for the mechanism of neonatal tolerance induction J. Exp. Med. 164:667.
11. O'Garra, A. and Murphy, K. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6:458.
12. Abbas, A. K., Murphy, K. M. and Sher, A. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
13. h2-like helper effectors. J. Immunol. 145:3796.
14. Lederer, J. A., Perez, V. L., DesRoches, L., Kim, S. M., Abbas, A. K. and Lichtman, A. H. 1996. Cytokine transcriptional events during helper T cell subset differentiation. J. Exp. Med. 184:397.
15. + T cells to enhance priming for IFN-γ production and diminishes IL-4 inhibition of such priming. Proc. Natl Acad. Sci. USA 90:10188.
16. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091.
17. h1 cells. J. Immunol. 146:3444.
18. h2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 9:145.
19. h2 responses. Immunol. Today 12:A49.
20. Huang, H., Hu-Li, J., Chen, H., Ben-Sasson, S. Z. and Paul, W. E. 1997. IL-4 and IL-13 production in differentiated T helper type 2 cells is not IL-4 dependent. J. Immunol. 159:3731.
21. h3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98:70.
22. Singh, R. R., Hahn, B. H. and Sercarz, E. E. 1996. Neonatal peptide exposure can prime T cells and, upon subsequent immunization, induce their immune deviation: implications for antibody vs. T cell-mediated autoimmunity [see comments]. J. Exp. Med. 183:1613.
23. H2 immunity in neonatal mice [see comments]. Science 271:1728.
24. Sarzotti, M., Robbins, D. S. and Hoffman, P. M. 1996. Induction of protective CTL responses in newborn mice by a murine retrovirus [see comments]. Science 271:1726.
25. Ridge, J. P., Fuchs, E. J. and Matzinger, P. 1996. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells [see comments]. Science 271:1723.
26. Ben-Nun, A., Wekerle, H. and Cohen, I. R. 1981. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11:195.
27. Karin, N., Szafer, F., Mitchell, D., Gold, D. P. and Steinman, L. 1993. Selective and nonselective stages in homing of T lymphocytes to the central nervous system during experimental allergic encephalomyelitis. J. Immunol. 150:4116.
28. Karin, N., Mitchell, J. D., Brocke, S., Ling, N. and Steinman, L. 1994. Reversal of experimental autoimmune encephalomyelitis by as soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of IFN-γ and TNF-α production. J. Exp. Med. 180:2227.
29. Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez, M. F., Steinman, L. and Karin, N. 1992. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356:63.
30. Brocke, S., Gijbels, K., Allegretta, M., Ferber, I., Piercy, C., Blankenstein, T., Martin, R., Utz, U., Karin, N., Mitchell, D., et al. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379:343.
31. Mor, F. and Cohen, I. R. 1995. Pathogenicity of T cells responsive to diverse cryptic epitopes of myelin basic protein in the Lewis rat. J. Immunol. 155:3693.
32. Butcher, E. C. and Picker, L. J. 1996. Lymphocyte homing and homeostasis. Science 272:60.
33. Weiner, H. L., Friedman, A., Miller, A., Khoury, S. J., al-Sabbagh, A., Santos, L., Sayegh, M., Nussenblatt, R. B., Trentham, D. E. and Hafler, D. A. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:809.
34. Janeway, C. A., Jr. 1992. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today. 13:11.
35. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991.
36. Steinman, L. and Conlon, P. 1997. Viral damage and the breakdown of self-tolerance. Nat. Med. 3:1085.
37. Miller, S. D. and Karpus, W. J. 1994. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol. Today 15:356.
38. + T cell-mediated pathology. J. Immunol. 156:4050.
39. Wucherpfennig, K. W. and Strominger, J. L. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695.
40. h2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:307.
41. Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M. and Rocken, M. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961.
42. Cash, E., Minty, A., Ferrara, P., Caput, D., Fradelizi, D. and Rott, O. 1994. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J. Immunol. 153:4258.
43. h2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
44. Leonard, J. P., Waldburger, K. E. and Goldman, S. J. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381.
45. h2 cells derived from the spleens of diabetic NOD mice. J. Clin. Invest. 95:2979.
46. h1 cells. J. Immunol. 155:5011.
47. Ando, D. G., Clayton, J., Kono, D., Urban, J. L. and Sercarz, E. E. 1989. Encephalitogenic T cells in the B10. PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell. Immunol. 124:132.
48. Katz, J. D., Benoist, C. and Mathis, D. 1995. T helper subsets in insulin dependent diabetes. Science 268:1185.
49. + T-cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today, 16:34.
50. H1-dependent autoimmune disease. Eur. J. Immunol. 23:3096.
51. Rapoport, M. J., Jaramillo, A., Zipris, D., Lazarus, A., Serreze, D. V., Leiter, E. H., Cyopick, P., Danska, J. S. and Delovitch, T. L. 1993. Interleukin-4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178:87.
52. Rott, O., Fleischer, B. and Cash, E. 1994. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1434.
53. h1 cells. Immunol. Today 14:335.
54. h2) responses to pancreatic islet autoantigens. J. Exp. Med. 186:2039.
55. Wu, B., Deng, C., Goluszko, E. and Christadoss, P. 1997. Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis. J. Immunol. 159:3016.
56. Karin, N., Binah, O., Grabie, N., Mitchel, D. J., Felzen, B., Solomon, M. D., Conlon, P., Gaur, A., Ling, N. and Steinman, L. 1998. Short peptide based tolerogens without antigenic activity reverse autoimmunity. J. Immunol. 160:5188.